Search research articles
Contact Us
Filters
Showing results (1551-1560 of 2,013) with videos related to
Page
of 202
Sort By:
Cancer Investigation
|
October 10, 2003
A phase II study of modified deGramont 5-fluorouracil, leucovorin, and oxaliplatin in previously treated patients with metastatic colorectal cancer
David P Ryan, Jeffrey W Clark, Matthew H Kulke, et al.
Journal of Applied Microbiology
|
February 16, 2012
Laboratory evaluation of large-scale decontamination approaches
M W Calfee, S P Ryan, J P Wood, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 28, 2002
Contacts with animals and humans as risk factors for adult brain tumours. An international case-control study
F Ménégoz, J Little, M Colonna, et al.
The Journal of Physical Chemistry. C, Nanomaterials and Interfaces
|
February 17, 2023
Donor-Acceptor Co-Adsorption Ratio Controls the Structure and Electronic Properties of Two-Dimensional Alkali-Organic Networks on Ag(100)
B Sohail, P J Blowey, L A Rochford, et al.
The American Journal of Sports Medicine
|
February 13, 2023
Incidence of Complications and Revision Surgery After High Tibial Osteotomy: A Systematic Review
Benjamin Miltenberg, Richard N Puzzitiello, Verdinand C B Ruelos, et al.
Chemical Communications (Cambridge, England)
|
May 16, 2014
Mapping functional groups on oxidised multi-walled carbon nanotubes at the nanometre scale
A E Goode, N D M Hine, S Chen, et al.
Journal of Dairy Science
|
April 3, 2017
Contribution of the novel sulfur-producing adjunct Lactobacillus nodensis to flavor development in Gouda cheese
Elaine O'Brien, Susan Mills, Alleson Dobson, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 14, 2006
Cell-cell signaling in Xanthomonas campestris involves an HD-GYP domain protein that functions in cyclic di-GMP turnover
Robert P Ryan, Yvonne Fouhy, Jean F Lucey, et al.
Cancer Chemotherapy and Pharmacology
|
December 20, 2005
Phase I clinical trial of the farnesyltransferase inhibitor BMS-214662 administered as a weekly 24 h continuous intravenous infusion in patients with advanced solid tumors
Joseph P Eder, David P Ryan, Leonard Appleman, et al.
Cancer Journal (Sudbury, Mass.)
|
November 6, 2002
A phase II study of troglitazone, an activator of the PPARgamma receptor, in patients with chemotherapy-resistant metastatic colorectal cancer
Matthew H Kulke, George D Demetri, Norman E Sharpless, et al.
Page
of 202
Search research articles
Search
Showing results (1551-1560 of 2,013) with videos related to
Sort By:
Page
of 202
Cancer Investigation
|
October 10, 2003
A phase II study of modified deGramont 5-fluorouracil, leucovorin, and oxaliplatin in previously treated patients with metastatic colorectal cancer
David P Ryan, Jeffrey W Clark, Matthew H Kulke, et al.
Journal of Applied Microbiology
|
February 16, 2012
Laboratory evaluation of large-scale decontamination approaches
M W Calfee, S P Ryan, J P Wood, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 28, 2002
Contacts with animals and humans as risk factors for adult brain tumours. An international case-control study
F Ménégoz, J Little, M Colonna, et al.
The Journal of Physical Chemistry. C, Nanomaterials and Interfaces
|
February 17, 2023
Donor-Acceptor Co-Adsorption Ratio Controls the Structure and Electronic Properties of Two-Dimensional Alkali-Organic Networks on Ag(100)
B Sohail, P J Blowey, L A Rochford, et al.
The American Journal of Sports Medicine
|
February 13, 2023
Incidence of Complications and Revision Surgery After High Tibial Osteotomy: A Systematic Review
Benjamin Miltenberg, Richard N Puzzitiello, Verdinand C B Ruelos, et al.
Chemical Communications (Cambridge, England)
|
May 16, 2014
Mapping functional groups on oxidised multi-walled carbon nanotubes at the nanometre scale
A E Goode, N D M Hine, S Chen, et al.
Journal of Dairy Science
|
April 3, 2017
Contribution of the novel sulfur-producing adjunct Lactobacillus nodensis to flavor development in Gouda cheese
Elaine O'Brien, Susan Mills, Alleson Dobson, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 14, 2006
Cell-cell signaling in Xanthomonas campestris involves an HD-GYP domain protein that functions in cyclic di-GMP turnover
Robert P Ryan, Yvonne Fouhy, Jean F Lucey, et al.
Cancer Chemotherapy and Pharmacology
|
December 20, 2005
Phase I clinical trial of the farnesyltransferase inhibitor BMS-214662 administered as a weekly 24 h continuous intravenous infusion in patients with advanced solid tumors
Joseph P Eder, David P Ryan, Leonard Appleman, et al.
Cancer Journal (Sudbury, Mass.)
|
November 6, 2002
A phase II study of troglitazone, an activator of the PPARgamma receptor, in patients with chemotherapy-resistant metastatic colorectal cancer
Matthew H Kulke, George D Demetri, Norman E Sharpless, et al.
Page
of 202